These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 22374865)
1. Generating orally active galanin analogues with analgesic activities. Robertson CR; Pruess TH; Grussendorf E; White HS; Bulaj G ChemMedChem; 2012 May; 7(5):903-9. PubMed ID: 22374865 [TBL] [Abstract][Full Text] [Related]
2. Incorporation of monodisperse oligoethyleneglycol amino acids into anticonvulsant analogues of galanin and neuropeptide y provides peripherally acting analgesics. Zhang L; Klein BD; Metcalf CS; Smith MD; McDougle DR; Lee HK; White HS; Bulaj G Mol Pharm; 2013 Feb; 10(2):574-85. PubMed ID: 23259957 [TBL] [Abstract][Full Text] [Related]
3. Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery. Robertson CR; Scholl EA; Pruess TH; Green BR; White HS; Bulaj G J Med Chem; 2010 Feb; 53(4):1871-5. PubMed ID: 20121116 [TBL] [Abstract][Full Text] [Related]
4. Analgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models. Metcalf CS; Klein BD; McDougle DR; Zhang L; Smith MD; Bulaj G; White HS J Pharmacol Exp Ther; 2015 Jan; 352(1):185-93. PubMed ID: 25347995 [TBL] [Abstract][Full Text] [Related]
5. Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2. Metcalf CS; Smith MD; Klein BD; McDougle DR; Zhang L; Bulaj G Neurochem Res; 2017 Jul; 42(7):1983-1994. PubMed ID: 28382595 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities. Bulaj G; Green BR; Lee HK; Robertson CR; White K; Zhang L; Sochanska M; Flynn SP; Scholl EA; Pruess TH; Smith MD; White HS J Med Chem; 2008 Dec; 51(24):8038-47. PubMed ID: 19053761 [TBL] [Abstract][Full Text] [Related]
7. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5. Hua XY; Hayes CS; Hofer A; Fitzsimmons B; Kilk K; Langel U; Bartfai T; Yaksh TL J Pharmacol Exp Ther; 2004 Feb; 308(2):574-82. PubMed ID: 14610237 [TBL] [Abstract][Full Text] [Related]
8. Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues. Zhang L; Robertson CR; Green BR; Pruess TH; White HS; Bulaj G J Med Chem; 2009 Mar; 52(5):1310-6. PubMed ID: 19199479 [TBL] [Abstract][Full Text] [Related]
9. Actions of several substituted short analogues of porcine galanin on isolated rat fundus strips: a structure-activity relationship. Korolkiewicz RP; Konstański Z; Rekowski P; Ruczyński J; Szyk A; Grzybowska M; Korolkiewicz KZ; Petrusewicz J J Physiol Pharmacol; 2001 Mar; 52(1):127-36. PubMed ID: 11321506 [TBL] [Abstract][Full Text] [Related]
10. The glycine residue in cyclic lactam analogues of galanin(1-16)-NH2 is important for stabilizing an N-terminal helix. Carpenter KA; Schmidt R; Yue SY; Hodzic L; Pou C; Payza K; Godbout C; Brown W; Roberts E Biochemistry; 1999 Nov; 38(46):15295-304. PubMed ID: 10563815 [TBL] [Abstract][Full Text] [Related]
11. Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055. Flynn SP; White HS Neuropeptides; 2015 Apr; 50():35-42. PubMed ID: 25690510 [TBL] [Abstract][Full Text] [Related]
12. Effects of porcine galanin, galanin(1-15)NH2 and its new analogues on glucose-induced insulin secretion. Ruczyński J; Cybal M; Wójcikowski C; Rekowski P Pol J Pharmacol; 2002; 54(2):133-41. PubMed ID: 12139110 [TBL] [Abstract][Full Text] [Related]
13. New galanin(1-15) analogues modified in positions 9, 10 and 11 act as galanin antagonists on glucose-induced insulin secretion. Olkowicz M; Ruczyński J; Cybal M; Konstański Z; Petrusewicz J; Kamińska B; Rekowski P J Physiol Pharmacol; 2007 Dec; 58(4):859-72. PubMed ID: 18195493 [TBL] [Abstract][Full Text] [Related]
14. Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models. White HS; Scholl EA; Klein BD; Flynn SP; Pruess TH; Green BR; Zhang L; Bulaj G Neurotherapeutics; 2009 Apr; 6(2):372-80. PubMed ID: 19332332 [TBL] [Abstract][Full Text] [Related]
15. The anticonvulsant action of the galanin receptor agonist NAX-5055 involves modulation of both excitatory- and inhibitory neurotransmission. Walls AB; Flynn SP; West PJ; Müller MS; Bak LK; Bulaj G; Schousboe A; White HS Epilepsy Res; 2016 Mar; 121():55-63. PubMed ID: 26894875 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological properties of new chimeric galanin analogue GAL(1-13)-[Ala10,11]ET-1(6-21)-NH2. Ruczyński J; Konstański Z; Cybal M; Petrusewicz J; Wójcikowski C; Rekowski P; Kamińska B J Physiol Pharmacol; 2005 Jun; 56(2):273-85. PubMed ID: 15985708 [TBL] [Abstract][Full Text] [Related]
17. Aspartimide modified galanin analogue antagonizes galanin action on insulin secretion. Ruczyński J; Konstański Z; Cybal M; Kocić I; Rekowski P Protein Pept Lett; 2010 Oct; 17(10):1182-8. PubMed ID: 20423319 [TBL] [Abstract][Full Text] [Related]
18. The novel anticonvulsant neuropeptide and galanin analogue, NAX-5055, does not alter energy and amino acid metabolism in cultured brain cells. Aldana BI; Waagepetersen HS; Schousboe A; White HS; Bulaj G; Walls AB J Neurosci Res; 2017 Nov; 95(11):2286-2296. PubMed ID: 28397993 [TBL] [Abstract][Full Text] [Related]
19. Effects of galanin, its analogues and fragments on rat isolated fundus strips. Katsoulis S; Schmidt WE; Schwörer H; Creutzfeldt W Br J Pharmacol; 1990 Oct; 101(2):297-300. PubMed ID: 1701674 [TBL] [Abstract][Full Text] [Related]
20. Central galanin receptor 2 mediates galanin action to promote systemic glucose metabolism of type 2 diabetic rats. Fang P; He B; Yu M; Shi M; Zhu Y; Zhang Z; Bo P Biochem Pharmacol; 2018 Oct; 156():241-247. PubMed ID: 30170096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]